Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Daratumumab and Ibrutinib for Symptomatic, Treatment-Naïve CLL: A Phase 1b Proof-of-Concept Study

Protocol: OSU-17143

Full Title

Daratumumab and Ibrutinib for Symptomatic, Treatment-Naïve CLL: A Phase 1b Proof-of-Concept Study

Leukemia Chronic Lymphocytic Leukemia